Alendronate in the treatment of Paget's disease of bone
- 31 March 1997
- Vol. 20 (3) , 263-271
- https://doi.org/10.1016/s8756-3282(96)00364-x
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Long-term elevation of 1,25-dihydroxyvitamin D after short-term intravenous administration of pamidronate (aminohydroxypropylidene bisphosphonate, APD) in paget's disease of boneJournal of Bone and Mineral Research, 1994
- The effects of the aminobisphosphonate alendronate on thyroid hormone-induced osteopenia in ratsCalcified Tissue International, 1993
- Effects of five daily 1 h infusions of alendronate in paget's disease of boneJournal of Bone and Mineral Research, 1992
- Spontaneous Fractures in a Patient Treated with Low Doses of Etidronic Acid (Disodium Etidronate)Drug Safety, 1992
- Effects of amino-butylidene diphosphonate in hypercalcemia due to malignancyBone, 1991
- BisphosphonatesDrugs, 1991
- Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committeeJournal of Bone and Mineral Research, 1987
- Long-Term Follow-up Observations on Treatment in Paget??s Disease of BonePublished by Wolters Kluwer Health ,1987
- Measuring serum calcium.BMJ, 1985
- 1,25-Dihydroxyvitamin D3 increases serum levels of the vitamin K-dependent bone proteinBiochemical and Biophysical Research Communications, 1981